Literature DB >> 24492692

Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B.

Hiroyuki Eguchi1, Munehisa Tsuruta, Junichi Tani, Reiichiro Kuwahara, Yuji Hiromatsu.   

Abstract

We herein present the case of a 58-year-old Japanese man with Fanconi's syndrome with a 13-month history of bone pain in his ribs, hips, knees and ankles. He had been receiving low-dose adefovir dipivoxil (ADV) for the treatment of lamivudine-resistant chronic hepatitis B virus infection for eight years and subsequently developed severe hypophosphatemia and proximal renal tubule dysfunction. Magnetic resonance imaging showed multiple insufficiency fractures in the ribs, ileum, tibia and calcaneus. Whole-body bone scintigraphy demonstrated increased uptake in those areas. Following dose reduction of ADV and the administration of treatment with calcitriol and phosphates, the patient's serum phosphate level increased and his clinical symptoms improved. Physicians prescribing ADV should carefully monitor the renal function and serum phosphate level.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24492692     DOI: 10.2169/internalmedicine.53.1213

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  12 in total

1.  A case of entecavir-induced Fanconi syndrome.

Authors:  Teruhiro Fujii; Kentaro Kawasoe; Akihito Ohta; Kosaku Nitta
Journal:  CEN Case Rep       Date:  2019-06-01

2.  Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B.

Authors:  Hong-Yu Jia; Feng Ding; Jian-Yang Chen; Jiang-Shan Lian; Yi-Min Zhang; Lin-Yan Zeng; Dai-Rong Xiang; Liang Yu; Jian-Hua Hu; Guo-Dong Yu; Huan Cai; Ying-Feng Lu; Lin Zheng; Lan-Juan Li; Yi-Da Yang
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

3.  Pathologic Femoral Neck Fracture Due to Fanconi Syndrome Induced by Adefovir Dipivoxil Therapy for Hepatitis B.

Authors:  Yoon-Suk Lee; Byung-Kook Kim; Ho-Jae Lee; Jinmyoung Dan
Journal:  Clin Orthop Surg       Date:  2016-05-10

4.  Adult-onset hypophosphatemic osteomalacia associated with Sjogren syndrome: Clinical case report.

Authors:  Guohua Shen; Yuwei Zhang; Shuang Hu; Bin Liu; Anren Kuang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 5.  Adverse effects of oral antiviral therapy in chronic hepatitis B.

Authors:  Bircan Kayaaslan; Rahmet Guner
Journal:  World J Hepatol       Date:  2017-02-18

6.  Osteomalacia and Fanconi Syndrome Induced by Adefovir.

Authors:  Natsumi Matsuoka; Haruhito A Uchida; Yoshikazu Hara; Hiroto Matsuda
Journal:  Intern Med       Date:  2019-02-01       Impact factor: 1.271

7.  Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible?

Authors:  Yan-Ying Qian; Zhi-Juan Dai; Lu-Ya Ruan; You-Jin Pan; Jian Jin; Meng-Te Shi; Yao-Xin Zhu; Chao-Ming Wu
Journal:  Drug Des Devel Ther       Date:  2019-04-10       Impact factor: 4.162

8.  Cross-sectional retrospective analysis of clinical characteristics of chronic hepatitis B patients with oral antiviral treatment in eastern China.

Authors:  Jueqing Gu; Guodong Yu; Xiaoli Zhang; Shanyan Zhang; Huan Cai; Chanyuan Ye; Yida Yang; Dezhou Li; Zhaowei Tong; Huajiang Shen; Huazhong Chen; Feng Ding; Xijie Lai; Junyan Liu; Meiling Xu; Weiti Wu
Journal:  Virol J       Date:  2021-01-13       Impact factor: 4.099

9.  Hypophosphatemic Osteomalacia with Multiple Bone Fractures: ADV-Induced Fanconi's Syndrome.

Authors:  Jee Hyuk Kim; Heung Yong Jin; Hong Sun Baek; Kyung Ae Lee
Journal:  Chonnam Med J       Date:  2018-01-25

10.  Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency.

Authors:  Ryo Koda; Masafumi Tsuchida; Noriaki Iino; Ichiei Narita
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.